GENOMIC CLEAVAGE MAP OF SALMONELLA-TYPHI TY2

被引:45
|
作者
LIU, SL [1 ]
SANDERSON, KE [1 ]
机构
[1] UNIV CALGARY, DEPT BIOL SCI, SALMONELLA GENET STOCK CTR, CALGARY, AB T2N 1N4, CANADA
关键词
D O I
10.1128/jb.177.17.5099-5107.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The genomic cleavage map of Salmonella typhi Ty2, 4,780 kb in size, was determined through digestion of the genomic DNA with endonucleases and separation of the fragments by pulsed-field gel electrophoresis. The chromosome has 33, 26, 7, and 35 sites for the enzymes XbaI, BlnI, I-CeuI, and SpeI, respectively. The fragments were arranged around the chromosome through excision of fragments from the gel, redigestion with a second enzyme, end labelling with P-32, and reelectrophoresis and named in alphabetical order. Tn10 transposons inserted in 82 different genes of Salmonella typhimurium were transduced by phage P22 into S. typhi, and the location of Tn10, and thus of the gene, was mapped through the XbaI and BlnI sites of Tn10. All seven I-CeuI sites (in rrl genes for 23S rRNA) were conserved, and the gene order within the I-CeuI fragments resembles that of S. typhimurium LT2, but the order of I-CeuI fragments is rearranged from ABCDEFG in S. typhimurium LT2 to AGCEFDB in S. typhi. In addition, there is a 500-kb inversion which covers the terminus region. Comparisons of lengths of segments between genes showed that S. typhi has segments which differ in size from those in S. typhimurium. The viaB locus, for synthesis of the Vi antigen of S. typhi, was shown to be within a 118-kb loop (a segment of DNA with no homolog in most other Salmonella species) between mel and poxA on the chromosome.
引用
收藏
页码:5099 / 5107
页数:9
相关论文
共 50 条
  • [1] Infection of Caenorhabditis elegans by Salmonella typhi Ty2
    Santander, J
    Espinoza, JC
    Campano, MS
    Robeson, J
    [J]. ELECTRONIC JOURNAL OF BIOTECHNOLOGY, 2003, 6 (02): : 148 - 152
  • [2] ISOLATION OF STABLE AROA MUTANTS OF SALMONELLA-TYPHI TY2 - PROPERTIES AND PRELIMINARY CHARACTERIZATION IN MICE
    DOUGAN, G
    MASKELL, D
    PICKARD, D
    HORMAECHE, C
    [J]. MOLECULAR & GENERAL GENETICS, 1987, 207 (2-3): : 402 - 405
  • [3] CONTROLLED FIELD TRIAL OF A TYPHOID VACCINE PREPARED WITH A NONMOTILE MUTANT OF SALMONELLA-TYPHI TY2
    WAHDAN, MH
    SIPPEL, JE
    MIKHAIL, IA
    RAHKA, AE
    ANDERSON, ES
    SPARKS, HA
    CVJETANOVIC, B
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1975, 52 (01): : 69 - 73
  • [4] HEMOLYTIC AND CHANNEL-FORMING PROPERTIES OF CHEMICALLY MODIFIED PORINS FROM SALMONELLA-TYPHI TY2
    LOBOS, S
    CALDERON, I
    MORA, G
    LABARCA, P
    [J]. ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES, 1984, 17 (02): : R153 - R153
  • [5] NATIVE AND CHEMICALLY MODIFIED PORIN CHANNELS FROM SALMONELLA-TYPHI TY2 IN PLANAR LIPID BILAYERS
    LABARCA, P
    LOBOS, S
    CALDERON, I
    MORA, G
    [J]. FEBS LETTERS, 1986, 197 (1-2) : 211 - 216
  • [7] THE HEMOLYTIC EFFECT OF SALMONELLA-TYPHI TY-2 PORINS
    CALDERON, I
    LOBOS, SR
    MORA, GC
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1984, 141 (03): : 579 - 583
  • [8] A GALE-VIA (VI-ANTIGEN-NEGATIVE) MUTANT OF SALMONELLA-TYPHI TY2 RETAINS VIRULENCE IN HUMANS
    HONE, DM
    ATTRIDGE, SR
    FORREST, B
    MORONA, R
    DANIELS, D
    LABROOY, JT
    BARTHOLOMEUSZ, RCA
    SHEARMAN, DJC
    HACKETT, J
    [J]. INFECTION AND IMMUNITY, 1988, 56 (05) : 1326 - 1333
  • [9] CONSTRUCTION OF A GENETICALLY DEFINED SALMONELLA-TYPHI TY2 AROA, AROC MUTANT FOR THE ENGINEERING OF A CANDIDATE ORAL TYPHOID TETANUS VACCINE
    CHATFIELD, SN
    FAIRWEATHER, N
    CHARLES, I
    PICKARD, D
    LEVINE, M
    HONE, D
    POSADA, M
    STRUGNELL, RA
    DOUGAN, G
    [J]. VACCINE, 1992, 10 (01) : 53 - 60
  • [10] MEMBRANE-ASSOCIATED RIBOSOMES IN SALMONELLA-TYPHI TY-2
    CALDERON, I
    MORA, G
    [J]. ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES, 1980, 13 (01): : 50 - 50